ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 15 as on 03-02-2023

Fund Performance

Fund Performance as on (19-Jan-23)

Return
1M
3M
6M
1Y
3Y
This Fund
-3.7%
-7.7%
-2.7%
-7.7%
17.8%
Benchmark
-2.3%
2.2%
9.6%
-0.5%
15%
Category
-3.4%
-8.1%
-1.7%
-8.3%
19.3%
About the Fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is an equity fund. This fund was started on  12 July, 2018. The fund is managed by Dharmesh Kakkad, Sharmila D’mello. The fund could potentially beat inflation in the long-run.

Key parameters

1) ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl has a NAV of 14.96 as on 03-02-2023.

2) ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl has 2514 Cr worth of assets under management (AUM) as on 31-12-2022 and is more than category average.

3) The fund has an expense ratio 1.21 %.

Fund Overview

Expense ratio
Expense ratio
1.21%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹2514 Cr
Inception Date
Inception Date
12 July, 2018
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹0
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
50.98%

Fund Distribution as on (31-Dec-22)

  • Equity 97.2%
  • Debt & Cash 2.8%
Size breakup
Large cap
44.3%
Mid cap
29%
Small cap
24%

Sector Allocation

Dec'22

Nov'22

Oct'22

Health

95.6%

Financial Services

4.4%

Top Holdings as on (31-Dec-22)

  • Equity
  • Debt & Cash
Equity Holdings31
Debt Holdings3

What changed

in last one month
  • Scheme
  • Portfolio
AUM decreased by 90.3 Cr in last 1M
Dec'22 return underperformed benchmark

Change in AUM

Dec'22
₹ 2.5K Cr
Nov'22
₹ 2.6K Cr
Oct'22
₹ 2.6K Cr

Fund Returns vs Benchmark

Jan'23
2.85%
5.37%
Dec'22
0.82%
2.63%
Nov'22
2.85%
5.37%
Fund Return
Benchmark Return

Concentration Analysis as on (31-Dec-22)

Fund
Dec'22
Nov'22
Oct'22
No of Holdings
34
32
33
Top 5 Company Concentration
40%
42.1%
42.2%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (16.9%)
Sun Pharmaceuticals Industries Ltd (17.1%)
Sun Pharmaceuticals Industries Ltd (16.6%)
No of Sectors
3
3
3
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (92.9%)
Health (91.6%)
Health (93.3%)

Fund Manager

Dharmesh Kakkad

Dharmesh Kakkad

Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl, since 2 May 2020
Sharmila D’mello

Sharmila D’mello

Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl, since 31 July 2022

AMC details

Fund House
ICICI Prudential Asset Management Company Limited
Total Schemes
Total AUM
₹4.81L Cr
as on 31-Dec-2022
Address
ICICI Prudential Asset Mgmt.Company Limited,3rd Floor, Hallmark Business Plaza,,Sant Dyaneshwar Marg,,Bandra (East)
Phone
+912226428000
Email
enquiry@icicipruamc.com

Fund Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 13.41% since inception which is less than its category average return of 14.87%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.23% in Equity, 0% in Debt and 2.77% in Cash related instruments
AUM size ₹2514 Cr

AUM size ₹2514 Cr

This fund has AUM of ₹2514 Cr which is more than its category average of ₹ 1318 Cr
Expense Ratio 1.21%

Expense Ratio 1.21%

This fund has an expense ratio of 1.21% which is less than its category average expense ratio of 1.54%

Frequently Asked Questions

The current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is 14.96 as on 03-Feb-2023.
Existing (Absolute + CAGR)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
Absolute Returns
CAGR Returns
1 Month Returns
-3.73%
-3.73%
6 Month Returns
-2.72%
-2.72%
1 Year Returns
-7.66%
-7.66%
3 Years Returns
63.55%
17.82%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.21 as on January 2023
2514 Cr as on January 2023
Sun Pharmaceuticals Industries Ltd(16.94%),Dr Reddy's Laboratories Ltd(8.26%),Lupin Ltd(5.09%),Apollo Hospitals Enterprise Ltd(4.91%),Alkem Laboratories Ltd(4.81%) as on January 2023
Health(92.92%),Financial Services(4.31%),Cash Equivalent(2.77%) as on January 2023
The alpha ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
-0.31
0.23
-
As on January 2023
The alpha for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
0.89
0.97
-
As on January 2023
The Beta for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
-0.76
0.64
-
As on January 2023
The sharpe ratio for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
12.67
22.73
-
As on January 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.37 as on January 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Dharmesh Kakkad,Sharmila D’mello are the fund managers of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
The Exit load of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is 1%

Mutual Fund execution provided by

Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.